• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial.

作者信息

Niyomnaitham Suvimol, Toh Zheng Quan, Licciardi Paul Vincent, Wongprompitak Patimaporn, Srisutthisamphan Kanjana, Copeland Katherine Kradangna, Chokephaibulkit Kulkanya

机构信息

Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700 Thailand; Siriraj Institute of Clinical Research (SICRES), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria 3052 Australia; Department of Pediatrics, The University of Melbourne, Parkville, Victoria 3010 Australia.

出版信息

J Infect. 2022 Oct;85(4):436-480. doi: 10.1016/j.jinf.2022.06.014. Epub 2022 Jun 18.

DOI:10.1016/j.jinf.2022.06.014
PMID:35728642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9212727/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867d/9212727/911858fa329b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867d/9212727/911858fa329b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/867d/9212727/911858fa329b/gr1_lrg.jpg

相似文献

1
Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial.单剂量BNT162b2、ChAdOx1 nCoV-19或科兴新冠疫苗对既往感染的成年人针对新冠病毒德尔塔和奥密克戎变异株的免疫原性：一项随机试验。
J Infect. 2022 Oct;85(4):436-480. doi: 10.1016/j.jinf.2022.06.014. Epub 2022 Jun 18.
2
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection.同源和异源 BNT162b2、CoronaVac 和 AZD1222 加强疫苗对 Delta 和奥密克戎 SARS-CoV-2 感染的真实世界有效性。
Emerg Microbes Infect. 2022 Dec;11(1):1343-1345. doi: 10.1080/22221751.2022.2072773.
3
Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study.比较德尔塔变异株主导大流行期间各种 COVID-19 疫苗方案的真实世界效果：一项病例对照研究。
Emerg Microbes Infect. 2022 Dec;11(1):585-592. doi: 10.1080/22221751.2022.2037398.
4
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.异源 ChAdOx1 nCoV-19 和 BNT162b2 疫苗加强接种可引发针对流行的 SARS-CoV-2 变体的强大中和抗体反应和 T 细胞反应性。
EBioMedicine. 2022 Jan;75:103761. doi: 10.1016/j.ebiom.2021.103761. Epub 2021 Dec 17.
5
Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies.智利科兴疫苗和加强针的血清学研究：抗 SARS-CoV-2 刺突抗体的免疫原性和持久性。
BMC Med. 2022 Jun 9;20(1):216. doi: 10.1186/s12916-022-02406-0.
6
Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19-BNT162b2 mRNA Vaccination.腺病毒载体 ChAdOx1 nCoV-19（阿斯利康-牛津）-BNT162b2 mRNA 疫苗异源接种对肺移植受者免疫原性的影响。
Viruses. 2022 Jul 2;14(7):1470. doi: 10.3390/v14071470.
7
Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2.针对 SARS-CoV-2 的三种不同疫苗加强免疫后的抗体反应动力学。
Front Immunol. 2022 Jan 19;13:811020. doi: 10.3389/fimmu.2022.811020. eCollection 2022.
8
Humoral immune response after different SARS-CoV-2 vaccination regimens.不同 SARS-CoV-2 疫苗接种方案后的体液免疫应答。
BMC Med. 2022 Jan 21;20(1):31. doi: 10.1186/s12916-021-02231-x.
9
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.在先前感染过 SARS-CoV-2 的医护人员中，单次接种 ChAdOx1 nCoV-19 疫苗后的抗体反应。
EBioMedicine. 2021 Aug;70:103523. doi: 10.1016/j.ebiom.2021.103523. Epub 2021 Aug 12.
10
Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination.细胞和体液免疫应答在异源和同源 SARS-CoV-2 疫苗接种中的相互关系。
Allergy. 2022 Aug;77(8):2381-2392. doi: 10.1111/all.15247. Epub 2022 Feb 16.

引用本文的文献

1
Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal study.两剂科兴疫苗接种方案（巴西Immunita-002）后儿童和青少年对奥密克戎亚型BA.1和BA.5的中和抗体反应：一项为期12个月的纵向研究
Front Immunol. 2025 Jul 15;16:1589733. doi: 10.3389/fimmu.2025.1589733. eCollection 2025.
2
Diverse BCR usage and T cell activation induced by different COVID-19 sequential vaccinations.不同序贯 COVID-19 疫苗接种诱导的不同 BCR 利用和 T 细胞激活。
mBio. 2024 Oct 16;15(10):e0142924. doi: 10.1128/mbio.01429-24. Epub 2024 Sep 9.
3
Comparison of Omicron and Delta Variants of SARS-CoV-2: A Systematic Review of Current Evidence.
奥密克戎和德尔塔变异株的比较：当前证据的系统评价。
Infect Disord Drug Targets. 2024;24(7):e050324227686. doi: 10.2174/0118715265279242240216114548.
4
SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.2020 年 3 月 1 日至 2023 年 1 月 31 日期间医护人员中 SARS-CoV-2 再感染情况。
Viruses. 2023 Jul 14;15(7):1551. doi: 10.3390/v15071551.
5
Considerations for vaccinating children against COVID-19.接种 COVID-19 疫苗的注意事项。
BMJ Paediatr Open. 2023 Jul;7(1). doi: 10.1136/bmjpo-2023-001964.
6
Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulation.儿童和青少年既往感染 SARS-CoV-2 后和单次接种 BNT162b2 疫苗对再感染的混合免疫：一项目标试验模拟。
Lancet Microbe. 2023 Jul;4(7):e495-e505. doi: 10.1016/S2666-5247(23)00103-9. Epub 2023 Apr 14.
7
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的德尔塔和奥密克戎变体：我们目前所了解的情况。
Vaccines (Basel). 2022 Nov 14;10(11):1926. doi: 10.3390/vaccines10111926.